BNTC vs WY · $388.7M cap vs P/E 43, rev $3.59B
Benitec Biopharma Ltd ADR (BNTC) versus Weyerhaeuser Company (WY) — a side-by-side from cached financials, not a winner call.
Benitec Biopharma Ltd ADR (BNTC) is a biotechnology company listed on NASDAQ.
Weyerhaeuser Company (WY) is a reit - specialty company listed on NYSE.
Latest reported BNTC revenue for 2026-03-31 was $0. Net income was -$32.7M. BNTC currently screens at market cap $388.7M.
Latest reported WY revenue for 2026-06-30 was $3.59B. Net income was $318.0M. WY currently screens at market cap $17.54B and trailing P/E 43.4.
BNTC currently screens at market cap $388.7M. WY currently screens at market cap $17.54B and trailing P/E 43.4.
Not investment advice. Open the BNTC and WY stock pages for the full models.
Not investment advice.